Liver function effects of SGLT2 inhibitor and GLP‐1 receptor agonist combination treatment in patients with type 2 diabetes (post hoc analysis of RECAP study)

ABSTRACT Aim The favor effect on liver disease by odium‐glucose cotransporter inhibitor (SGLT2i) and GLP‐1 receptor agonist (GLP1Ra) was reported; however, the effect of the combination treatment of these drugs was not well known. Methods We retrospectively analyzed data for 643 patients with type 2...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Daisuke Tsuriya, Kazuo Kobayashi, Kei Takeshita, Takuya Hashimoto, Moritsugu Kimura, Yoshimi Muta, Hisashi Yokomizo, Yuichi Takashi, Shunichiro Tsukamoto, Kouichi Tamura, Keizo Kanasaki, Daiji Kawanami, Masao Toyoda
Format:	Artigo
Jezik:	Inglês
Izdano:	Wiley 2025-07-01
Serija:	Journal of Diabetes Investigation
Teme:	FIB‐4 index GLP‐1 receptor agonist Sodium‐glucose cotransporter inhibitor
Online dostop:	https://doi.org/10.1111/jdi.70066
Oznake:	Označite Brez oznak, prvi označite!